Lipoprotein(a): A Genetically Determined, Causal, and Prevalent

Lipoprotein(a)

Lp(a): Looking Beyond LDL to Assess ASCVD Risk - PCNA

Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule

Frontiers Causal effects of genetically predicted type 2 diabetes mellitus on blood lipid profiles and concentration of particle-size-determined lipoprotein subclasses: A two-sample Mendelian randomization study

The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis, European Journal of Medical Research

Lipoprotein(a) and Cardiovascular Risk

PDF) Lipoprotein(a): An Independent, Genetic and Causal Factor for Cardiovascular Disease and Acute Myocardial Infarction

Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease

Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases

Clinical Feature: The ABCs of Lipoprotein(a)

Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease

Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events

LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development

Cover Story Emerging From the Shadows: Lp(a) - American College of Cardiology